A detailed history of Stifel Financial Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 39,921 shares of GH stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,921
Previous 40,155 0.58%
Holding current value
$1.26 Million
Previous $1.16 Million 21.05%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $5,218 - $8,491
-234 Reduced 0.58%
39,921 $915,000
Q2 2024

Aug 13, 2024

BUY
$16.07 - $31.84 $229,029 - $453,783
14,252 Added 55.02%
40,155 $1.16 Million
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $786,044 - $1.23 Million
-45,887 Reduced 63.92%
25,903 $534,000
Q4 2023

Feb 12, 2024

SELL
$21.58 - $29.5 $118,021 - $161,335
-5,469 Reduced 7.08%
71,790 $1.94 Million
Q3 2023

Nov 13, 2023

SELL
$25.8 - $39.97 $163,262 - $252,930
-6,328 Reduced 7.57%
77,259 $2.29 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $163,562 - $296,896
7,811 Added 10.31%
83,587 $2.99 Million
Q1 2023

May 12, 2023

BUY
$22.92 - $33.76 $183,428 - $270,181
8,003 Added 11.81%
75,776 $1.78 Million
Q4 2022

Feb 13, 2023

SELL
$25.44 - $59.78 $740,405 - $1.74 Million
-29,104 Reduced 30.04%
67,773 $1.84 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $412,237 - $575,962
9,442 Added 10.8%
96,877 $5.22 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $165,080 - $443,060
5,728 Added 7.01%
87,435 $3.53 Million
Q1 2022

May 13, 2022

BUY
$48.25 - $100.49 $284,144 - $591,785
5,889 Added 7.77%
81,707 $5.41 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $1.52 Million - $2.06 Million
17,146 Added 29.22%
75,818 $7.58 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $441,106 - $590,271
-4,466 Reduced 7.07%
58,672 $7.33 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $1.38 Million - $2.08 Million
12,538 Added 24.78%
63,138 $7.84 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $464,712 - $655,147
3,658 Added 7.79%
50,600 $7.73 Million
Q4 2020

Feb 12, 2021

BUY
$99.96 - $135.93 $85,565 - $116,356
856 Added 1.86%
46,942 $6.05 Million
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $80,801 - $112,470
-1,006 Reduced 2.14%
46,086 $5.15 Million
Q2 2020

Aug 14, 2020

SELL
$60.49 - $97.5 $88,859 - $143,227
-1,469 Reduced 3.03%
47,092 $3.82 Million
Q1 2020

May 14, 2020

BUY
$59.04 - $88.81 $2.68 Million - $4.03 Million
45,400 Added 1436.25%
48,561 $3.39 Million
Q4 2019

Feb 13, 2020

SELL
$59.49 - $82.78 $28,971 - $40,313
-487 Reduced 13.35%
3,161 $251,000
Q3 2019

Nov 13, 2019

SELL
$62.59 - $110.3 $517,431 - $911,850
-8,267 Reduced 69.38%
3,648 $226,000
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $761,845 - $1.09 Million
11,915 New
11,915 $1.03 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.24B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.